S6E13: 7. Laws, guidelines and best practices in new drug development

<p>Our 7th podcast in the series <a href='https://www.pituitaryworldnews.org/category/podcasts/'> "The Journey to a New Drug," </a>dives into the regulatory environment with <a href='https://www.crinetics.com'>Crinetics Pharmaceuticals</a> regulatory affairs team, Senior Director Michael Monahan, and Operations Manager Debbie Koh Mendez. Crinetics is developing several<a href='https://www.crinetics.com/for-patients/'> new oral drugs for Acromegaly and Cushing's.</a>  This podcast is an engaging talk rich with information from two extremely experienced executives. They give us a thorough insiders look at their work with regulatory agencies in the US and Europe. And, given the current issues with COVID-19 vaccine and therapy development, this podcast offers a very educational, timely discussion.  So if you want to learn more about the regulations for the approval of new drugs this is your chance.</p> <p>Toward the end of the podcasts, don't miss a great discussion on the latest trend in patient involvement and seeking patient insight in the regulatory environment.</p>